InsidersTradesSigma
Explore the complete record of transactions filed by JACOB GARY S, Chairman & CEO. Director active across 1 company, notably OKYO Pharma Ltd. In total, 1 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €47k. Activity tracked since 19 May 2022. The latest transaction was filed on 19 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Gary S. Jacob is the Chief Executive Officer of OKYO Pharma Ltd. He leads the company with a vision focused on innovation in the pharmaceutical field, aiming to develop innovative treatments for patients.